October 28th, 2013

Devicare today announced the signing of a cooperation agreement with the Autonomous University of Barcelona (UAB) in order to jointly develop new products and services in the field of renal lithiasis.

Devicare will work with the Chemical Separations Technical Group of  UAB, which under the leadership of Dr. Manuel Valiente has become one of the leading research groups in the analysis of the formation of kidney stones nationwide.

With this collaboration agreement, Devicare expects to increase scientific knowledge in this therapeutic area and add new products to its pipeline.